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Caspase-1-Independent, Fas/Fas Ligand±Mediated
IL-18 Secretion from Macrophages
Causes Acute Liver Injury in Mice
Introduction
IL-18 is a potent pleiotropic cytokine (Okamura et al.,
1995, 1998a, 1998b; Dinarello et al., 1998). IL-18 induces
IFNg production by lymphocytes, such as T cells and
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Figure 1. Mature IL-18 Secretion from P.
acnes-Elicited Macrophages by Stimulation
with FasL
(A) IL-18 secretion by FasL-stimulated mac-
rophages. Kupffer cells (left) or splenic mac-
rophages (splenic mù, right) (1 3 106/ml) were
prepared from P. acnes-primed C57BL/6
mice (WT, closed column) or caspase-1-defi-
cient mice (ICEKO, open column). The cells
were incubated with 1 mg/ml of LPS, 2 3 106/
ml of mFasL cells, or 2 3 106/ml of LNK5E3
cells in the presence of 10 mg/ml anti-mouse
FasL mAb (a-FasL) or control hamster IgG (C)
for 24 hr. The cells were also incubated with
20 ng/ml of rFasL in the presence of 50 mg/ml
of anti-human FasL mAb (a-hFasL) or control
isotype-matched mouse IgG (C) for 24 hr. IL-
18 in the supernatant was measured by
ELISA. Data are indicated as mean 6 SD of
triplicated cultures and represent one of three
experiments with similar results. ND, not de-
tectable. (B) Secretion of biologically active
IL-18 from FasL-stimulated macrophages.
LNK5E3 cells (1 3 106/ml) were incubated
with each supernatant shown in (A) in the
presence or absence of 100 mg/ml of neu-
tralizing anti-IL-18 antibody and 100 pg/ml of
IL-12 for 48 hr. Concentration of IFNg in each
supernatant was determined by ELISA. IL-18
activity was calculated as described in the
Experimental Procedures. Data are indicated
as mean 6 SD of triplicated cultures and are
representative of three independent experi-
ments with similar results. ND, not de-
tectable.
acnes-primed caspase-1-deficient mice as well as wild- mice, indicating that IL-18 release from LPS-stimulated
macrophages totally depends on caspase-1, as demon-type C57BL/6 mice, both leading to acute liver injury.
In contrast, the same treatment did not cause liver injury strated previously (Gu et al., 1997). We also demon-
strated FasL-stimulated IL-18 secretion from P. acnes-in P. acnes-primed IL-18-deficient mice, indicating the
critical role of IL-18 in the FasL-induced liver injury. elicited splenic macrophages. As shown in Figure 1A,
right, comparable levels of IL-18 were also detected in
the supernatant of P. acnes-elicited splenic macro-Results
phages from wild-type C57BL/6 mice and caspase-1-
deficient mice upon stimulation by mFasL cells, LNK5E3Caspase-1-Independent IL-18 Secretion
from FasL-Stimulated Macrophages cells, or rFasL. The prerequisite of caspase-1 for LPS-
stimulated secretion of IL-18 was also the case for P.To investigate whether IL-18 can be secreted from FasL-
stimulated macrophages in a caspase-1-independent acnes-elicited splenic macrophages. Both Kupffer cells
and splenic macrophages from nontreated wild-type ormanner, we incubated Kupffer cells or splenic macro-
phages from P. acnes-primed wild-type C57BL/6 mice caspase-1-deficient mice did not release IL-18 after the
stimulation with FasL (data not shown), suggesting thator caspase-1-deficient mice (presented as ICEKO in the
following figures) with murine FasL-transfected L5178Y the P. acnes priming is a prerequisite for making macro-
phages competent to respond to the FasL-stimulated(mFasL) cells, constitutively FasL-expressing cloned he-
patic NK (LNK5E3) cells, or rFasL. As shown in Figure IL-18 secretion.
In order to examine biological activity of IL-18 se-1A, left, P. acnes-elicited Kupffer cells from wild-type
and caspase-1-deficient mice secreted comparable lev- creted from the FasL-stimulated Kupffer cells or macro-
phages, we measured IFNg production by LNK5E3 cellsels of IL-18 after stimulation with FasL transfectants or
LNK5E3 cells as determined by ELISA. This secretion of incubated with the supernatants from FasL-stimulated
cells. As shown in Figure 1B, left, the supernatant ofIL-18 was inhibited by neutralizing mAb against murine
FasL, indicating that IL-18 secretion from P. acnes-elic- FasL-stimulated P. acnes-elicited Kupffer cells from ei-
ther wild-type C57BL/6 mice or caspase-1-deficientited Kupffer cells was induced by murine FasL ex-
pressed on those cells. IL-18 secretion was also induced mice induced IFNg production by LNK5E3 cells, indicat-
ing that IL-18 secreted by these cells had biologicalby rFasL, indicating that FasL can solely induce IL-18
secretion from P. acnes-primed Kupffer cells in a cas- activity. Similar results were obtained with the FasL-
stimulated splenic macrophages (Figure 1B, right). Thepase-1-independent manner (Figure 1A). In contrast,
LPS stimulation did not induce IL-18 secretion from the biological activities in the supernatants from LPS- or
FasL-stimulated macrophages were well correlated withKupffer cells from P. acnes-primed caspase-1-deficient
FasL-Stimulated IL-18 Secretion from Macrophages
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either caspase-1-deficient or wild-type C57BL/6 mice,
which was just the same size as the mature IL-18 found
in LPS-activated Kupffer cell supernatant (Gu et al.,
1997). Therefore, IL-18 can be processed at a site close
to the cleavage site for caspase-1 in FasL-stimulated
Kupffer cells independently of caspase-1.
In order to test involvement of caspases other than
caspase-1, we incubated the macrophages with general
inhibitors for caspase. As shown in Figure 2B, both
Z-VAD-FMK (ZVAD) and Ac-YVAD-CMK (YVAD) inhib-
ited IL-18 secretion from the macrophages as well as
their apoptosis. Therefore, some caspase other than
caspase-1 is involved in the processing of proIL-18 in
FasL-stimulated macrophages. It was also noted that
IL-18 secretion from FasL-stimulated macrophages was
not strictly correlated with their apoptosis as observed
at 5 ng/ml of rFasL (Figure 2B). Similar results were
obtained from P. acnes-elicited macrophages from
caspase-1-deficient mice (data not shown).
Fas Expression on P. acnes-Elicited Macrophages
To investigate a mechanism of P. acnes-induced sensiti-
zation to FasL, we examined Fas expression on macro-
phages before and after the treatment with P. acnes.
As shown in Figure 3, Mac1-positive Kupffer cells from
Figure 2. Caspase-Dependent IL-18 Secretion from FasL-Stimu- both wild-type and caspase-1-deficient mice expressed
lated P. acnes-Elicited Macrophages Fas at high levels after in vivo administration of P. acnes,
(A) Secretion of 18 kDa mature IL-18 from rFasL-stimulated P. acnes- while those from nontreated mice did not express Fas.
elicited Kupffer cells. P. acnes-elicited Kupffer cells from wild-type In accordance with Fas expression, IL-18 was not de-
C57BL/6 mice (WT) or caspase-1-deficient mice (ICEKO) were incu-
tected in their supernatants when Kupffer cells orbated with [35S]-methionine/cysteine in the presence or absence of
splenic macrophages from nontreated mice were incu-1 mg/ml LPS or 20 ng/ml of rFasL for 5 hr. The resulting supernatant
was immunoprecipitated using protein G-Sepharose and anti-IL- bated with mFasL or rFasL (data not shown). These
18 antibody. Metabolically labeled IL-18 in each supernatant was results suggest that P. acnes priming is required for
determined by SDS-PAGE and autoradiography. Arrow indicates 18 sensitizing macrophages to FasL-stimulated IL-18 se-
kDa mature IL-18. cretion by upregulating Fas expression on these cells.
(B) Inhibitory effect of caspase inhibitors on IL-18 secretion from
As IFNg has been reported to upregulate Fas expres-rFasL-stimulated macrophages. P. acnes-elicited splenic macro-
sion on macrophages in vitro (Spanaus et al., 1998), wephages from C57BL/6 mice were incubated with various doses of
rFasL in the presence of 20 mM Z-VAD-FMK (ZVAD), 20 mM Ac- next examined the Fas expression on Kupffer cells from
YVAD-CMK (YVAD), or the same volume of DMSO (vehicle) for 24 IFNg-deficient mice before and after the treatment with
hr. IL-18 in each supernatant was measured by ELISA (left). The P. acnes. As shown in Figure 3, P. acnes treatment
cells were analyzed for apoptosis by the pattern of nuclear staining did not induce Fas expression on the IFNg-deficient
with propiodium iodide (right). Data are indicated as mean 6 SD of
macrophages. Similar results were obtained for splenictriplicated cultures and representative of three independent experi-
macrophages (data not shown). Interestingly, IL-18-defi-ments with similar results. ND, not detectable.
cient macrophages were able to induce Fas expression
after P. acnes treatment, suggesting that IFNg induced
by other cytokines, such as IL-12 (Matsui et al., 1997),the IL-18 levels determined by ELISA (Figure 1A), sug-
contributes to this process. These results indicate thatgesting that the IL-18 secreted from the FasL-stimulated
IFNg plays an essential role in P. acnes-induced upregu-Kupffer cells or macrophages in a caspase-1-indepen-
lation of Fas expression on macrophages.dent manner has equivalent activity to the conventional
IL-18 secreted from the LPS-stimulated macrophages
in a caspase-1-dependent manner. Induction of IL-18-Dependent Acute Liver Injury
by In Vivo Administration of Soluble FasL
The in vitro stimulation with rFasL induced secretion ofAbrogation of Fas-Mediated IL-18 Secretion
by Caspase Inhibitors IL-18 from P. acnes-primed macrophages (Figure 1). To
investigate the FasL-stimulated IL-18 secretion in vivo,To investigate whether the FasL-stimulated IL-18 secre-
tion from P. acnes-elicited Kupffer cells is associated we administered rFasL in nontreated or P. acnes-primed
mice. As shown in Figure 4A, serum IL-18 levels werewith the processing of IL-18, as observed in the case
of LPS-stimulated P. acnes-elicited Kupffer cells (Gu et increased after administration of rFasL in P. acnes-
primed wild-type C57BL/6 mice, while those of non-al., 1997), we performed immunoprecipitation of meta-
bolically labeled IL-18 from the supernatant of rFasL- treated wild-type C57BL/6 mice remained unchanged.
IL-18 secreted in the sera had IFNg-inducing activityor LPS-stimulated Kupffer cells. As shown in Figure 2A,
an 18 kDa form of IL-18 was detected in the supernatant (data not shown). As expected from the in vitro results,
P. acnes-treated caspase-1-deficient mice showed theof rFasL-stimulated P. acnes-elicited Kupffer cells from
Immunity
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Figure 4. IL-18 Is Required for rFasL-Induced Liver Injury
Figure 3. Fas Expression on P. acnes-Elicited Kupffer Cells
(A) Elevated serum IL-18 levels after administration of rFasL into P.
Kupffer cells were isolated from nontreated or P. acnes-primed wild-
acnes-primed mice. rFasL (500 ng, closed column) or the same
type C57BL/6 mice (WT), caspase-1-deficient mice (ICEKO), and
volume of PBS (open column) was i.v. administered into P. acnes-
IFNg-deficient mice (IFNgKO). Splenic macrophages were from non-
primed or nontreated wild-type C57BL/6 mice (WT), IFNg-deficient
treated or P. acnes-primed IL-18-deficient mice (IL-18KO). The cells
mice (IFNgKO), IL-18-deficient mice (IL-18KO), or caspase-1-defi-
were stained with PE-conjugated anti-Fas and FITC-conjugated
cient mice (ICEKO). In some groups, 1 mg of neutralizing anti-human
anti-Mac1 mAbs and analyzed by flow cytometry. The figure is repre-
FasL mAb (a-hFasL) was i.p. administered 1 hr before. After 24 hr,
sentative of three independent experiments with similar results.
serum was sampled, and IL-18 in the serum was determined by
ELISA. Data represent mean 6 SD of five mice in each experimental
group. Similar results were obtained in three independent experi-
ments.elevated serum level of IL-18 after administration of
(B) Elevated serum liver enzyme levels after treatment with rFasL.rFasL, which was comparable to that in wild-type
GPT was measured in each serum from the mice shown in (A). DataC57BL/6 mice. This indicates that FasL-stimulated IL-
represent mean 6 SD of five mice in each group. Similar results
18 secretion from P. acnes-primed macrophages is cas- were obtained in three independent experiments.
pase-1 independent also in vivo. In contrast, IL-18 eleva- (C) Fas-dependent apoptosis of P. acnes-elicited IL-18-deficient
tion was not observed in IFNg-deficient mice (Figure macrophages. Splenic macrophages were isolated from nontreated
(open column) or P. acnes-primed (closed column) wild-type4A), possibly due to lack of Fas expression after P. acnes
C57BL/6 mice (WT), IL-18-deficient mice (IL-18KO), IFNg-deficientpriming (Figure 3).
mice (IFNgKO), or caspase-1-deficient mice (ICEKO) and incubatedNext, we examined the biological consequences of
with 20 ng/ml of rFasL for 48 hr followed by PI staining. Data are
FasL-induced IL-18 secretion in P. acnes-primed mice. represented as mean 6 SD of triplicated cultures. Similar results
It has been reported that liver injury could not be readily were obtained in three independent experiments.
induced by the administration of rFasL unless the mice
had been treated with P. acnes (Tanaka et al., 1997).
levels in P. acnes and rFasL-treated mice with variousThis prompted us to address the possibility that rFasL-
genomic mutations. As expected, P. acnes-primed wild-induced IL-18 secretion might play a critical role in in-
type C57BL/6 mice showed acute liver injury after rFasLduction of acute liver injury, rather than direct cytotoxic
challenge, whereas nontreated wild-type C57BL/6 miceaction of rFasL against liver parenchymal cells. To inves-
tigate this possibility, we measured serum liver enzyme did not suffer from liver injury. A comparable level of
FasL-Stimulated IL-18 Secretion from Macrophages
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liver injury was caused in caspase-1-deficient mice, indi-
cating that caspase-1 is dispensable for this liver injury.
In contrast, neither IL-18-deficient nor IFNg-deficient
mice suffered from liver injury (Figure 4B). The suscepti-
bility of the mice to this liver injury was well correlated
with the elevated serum IL-18 levels shown in Figure
4A. As shown in Figures 3 and 4C, splenic macrophages
from IL-18-deficient mice expressed Fas after P. acnes
treatment and underwent apoptosis by rFasL stimula-
tion in vitro similarly to those from wild-type C57BL/6
mice, indicating that P. acnes-elicited macrophages in
IL-18-deficient mice expressed functional Fas on their
surface. Thus, these results indicated that IL-18 plays
a critical role in induction of acute liver injury by rFasL
in P. acnes-primed mice.
To confirm that IL-18 induces liver injury in P. acnes-
primed mice, we sequentially administered P. acnes and
IL-18 into wild-type C57BL/6 mice. As shown in Figure
5A, acute liver injury was induced in either wild-type
or IL-18-deficient mice, indicating that some effector
mechanism for liver injury that acts downstream of IL-
18 is intact in IL-18-deficient mice.
To investigate whether endogenous FasL is involved
in IL-18-induced liver injury, we administered neutraliz-
ing anti-mouse FasL mAb at IL-18 challenge. As shown
in Figure 5B, left, anti-murine FasL mAb partially inhib-
ited the liver injury. We also sequentially administered
Figure 5. IL-18-Induced Acute Liver InjuryP. acnes and IL-18 into C57BL/6 gld/gld (gld/gld) mice,
(A) Induction of acute liver injury by IL-18 in P. acnes-primed mice.lacking functional FasL (Takahashi et al., 1994). As
IL-18 (500 ng, closed column) or control PBS (open column) wasshown in Figure 5B, right, the liver injury in gld/gld mice
i.p. administered into P. acnes-primed wild-type C57BL/6 mice (WT)
was significantly milder than that in wild-type mice. or IL-18-deficient mice (IL-18KO). After 24 hr, the serum was sam-
Since IL-18 induces production of IFNg, we also exam- pled for measuring liver enzyme levels (left), and the liver specimens
ined a possible involvement of IFNg in the P. acnes/IL- were subjected to HE staining (right). Arrows indicate necrotic le-
sion. A representative lesion of one mouse among five mice in each18-induced liver injury. As shown in Figure 5B, IFNg-
experimental group is shown. Similar results were obtained in threedeficient mice showed milder liver injury than wild-type
independent experiments.mice. These results suggested that IL-18-induced liver
(B) Involvement of endogenous FasL and IFNg in IL-18-induced
injury is at least partly mediated by both endogenous liver injury. Left, P. acnes-primed wild-type C57BL/6 mice were i.p.
FasL and IFNg, the latter of which may then stimulate administered with IL-18 (500 ng) in the presence of neutralizing anti-
macrophages to produce a powerfully hepatotoxic fac- mouse FasL mAb (a-FasL, closed column) or control IgG (Cont.,
open column). Serum GPT levels were determined 24 hr after. Datator, TNFa, as shown previously (Tsutsui et al., 1997).
are indicated as mean 6 SD of five mice in each group and represen-
tative of three independent experiments with similar results. Aster-
Discussion isk, p , 0.05. Right, P. acnes-primed wild-type C57BL/6 mice (WT,
n 5 20), gld/gld mice (gld/gld, n 5 20), or IFNg-deficient mice (IFN-
In the present study, we demonstrated that P. acnes- gKO, n 5 11) were i.p. administered with IL-18 (500 ng). Serum GPT
levels were determined 24 hr after. Data are indicated as mean 6primed macrophages secrete biologically active IL-18
SD. Double asterisks, p , 0.01.upon stimulation with FasL. The P. acnes priming ren-
dered macrophages responsive to FasL stimulation by
upregulating Fas expression in an IFNg-dependent man- processing of IL-1b has also been noted in FasL-stimu-
lated neutrophils (Miwa et al., 1998). In both cases, pro-ner. In contrast to the LPS-stimulated IL-18 secretion
that was strictly caspase-1 dependent, the FasL-stimu- cessing was blocked by caspase inhibitors, and secre-
tion of these cytokines did not correlate to apoptosislated IL-18 secretion appeared to be mediated by some
caspase other than caspase-1. In addition, we revealed (Miwa et al., 1998; Figure 2B). To date, the only caspases
known to cleave pro-IL-18 are caspase-1, caspase-4,that the FasL-stimulated IL-18 secretion from primed
macrophages plays a critical role in the pathogenesis and caspase-3, while caspase-3 leads to production of
biologically inactive fragments (Akita et al., 1997; Gu etof FasL-induced liver injury.
It has been shown that IL-18 secretion from LPS- al., 1997). Biochemical characterization of IL-18 se-
creted from FasL-stimulated, caspase-1-deficient mac-stimulated macrophages requires processing by cas-
pase-1 (Ghayur et al., 1997; Gu et al., 1997). We here rophages showed almost the same size as the conven-
tional IL-18 secreted from LPS-stimulated macrophagesalso observed that P. acnes-primed macrophages from
caspase-1-deficient mice did not secrete IL-18 upon (Figure 2A), suggesting that alternative processing en-
zyme might have caspase-1-like specificity. It has beenLPS stimulation (Figure 1). In contrast to the caspase-
1-dependent IL-18 secretion upon LPS stimulation, the reported that cotransfection of caspase-4 and proIL-18
into COS cells resulted in intracellular cleavage of proIL-FasL-stimulated IL-18 secretion was totally caspase-1
independent (Figure 1). A similar caspase-independent 18 into biologically active IL-18 of 18 kDa (Gu et al.,
Immunity
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1997). Therefore, caspase-4 seems to be the most likely FasL action appears to induce IL-18 secretion from mac-
rophages rather than to directly induce hepatocyte apo-candidate. Interestingly, proIL-1b also can be cleaved
by multiple enzymes including caspase-1, and the cleav- ptosis. We have shown that IL-18 augments cytotoxic
activities of NK cells and T cells by upregulating mem-age sites cluster around the site cleaved by caspase-1
(Fantuzzi et al., 1997). Alternatively, a protease(s) acti- brane FasL expression on these cells and by enhancing
perforin-mediated cytotoxicity (Dao et al., 1996; Tsutsuivated by caspases would process IL-18 in FasL-stimu-
lated macrophages. Recently, proteinase-3, which is a et al., 1996; Hyodo et al., 1999). Our present results
demonstrate that IL-18-induced liver injury was at leastserine protease stored in cytoplasmic granules of neu-
trophils and monocytes, has been reported to be an partly mediated by endogenous FasL and IFNg possibly
induced by IL-18 (Figure 5B). Therefore, the solublealternative processing enzyme for IL-1b and IL-18
(Coeshott et al., 1999; Fantuzzi and Dinarello, 1999). FasL-stimulated IL-18 secretion from macrophages
plays an amplifying role in the development of liverFurther studies are now under way to characterize the
molecular mechanism for caspase-1-independent IL-18 injury.
Administration of IL-18 solely induced liver injury insecretion from FasL-stimulated macrophages.
It has been reported that liver injury could not be P. acnes-primed mice (Figure 5A), whereas it did not
cause any liver damage in nontreated mice (data notreadily induced by the administration of rFasL unless
the mice had been primed with P. acnes (Tanaka et al., shown). This is partly because P. acnes treatment in-
duces responsiveness of hepatic lymphocytes to the1997). However, the reasons why only P. acnes-primed
mice are sensitive to FasL-induced liver injury have not stimulation with IL-18 (Matsui et al., 1997). As previously
reported, splenic T cells require IL-12 stimulation to ex-been completely understood. Here, we demonstrated
that one of the roles of P. acnes treatment is to induce press IL-18R (Yoshimoto et al., 1998). This is also the
case for hepatic lymphocytes. Hepatic T cells fromfunctional Fas expression on macrophages, presumably
by endogenous accumulation of IFNg. As previously re- nontreated mice do not express IL-18R. However, P.
acnes-primed hepatic T cells expressed IL-18R on theirported (Matsui et al., 1997), P. acnes-elicited Kupffer
cells secrete IL-12, which stimulates local NK cells and surface, as determined by flow cytometry (K. M., unpub-
lished data). IL-18-induced liver injury is partly due toT cells to produce IFNg that in turn stimulates Kupffer
cells to upregulate their functional Fas expression (Fig- the upregulation of endogenous FasL expression and
also to the induction of IFNg production, presumablyure 3). In fact, Fas expression was not observed in mac-
rophages derived from P. acnes-primed IFNg-deficient leading to the sequential activation of proinflammatory
cytokine cascade, as previously reported (Tsutsui et al.,mice (Figure 3). Consequently, IL-18 serum level did not
increase in these mice lacking Fas-expressing macro- 1997) (Figure 5B). Additionally, IFNg plays a critical role
in upregulation of Fas on Kupffer cells. Therefore, IFNgphages even after administration of rFasL (Figure 4A). In
addition, P. acnes treatment induces multiple granuloma contribute to liver injury by induction of Fas at priming
phase and of TNFa production at effector phase.formation mainly consisting of macrophages/Kupffer
cells and lymphocytes in the liver as recently shown Here, we demonstrate that the activation of Fas in-
duces IL-18 secretion from IFNg-primed macrophages.(Sakao et al., 1999). Indeed, the number of Kupffer cells
and splenic macrophages of P. acnes-treated mice was IFNg plays a critical role in host defense against infection
with intracellular microbes (Cooper et al., 1993; Dai etelevated by about 20- and 5-fold, respectively, in those
from nontreated mice (data not shown). This accumula- al., 1997). IL-18 and IL-12 participate in host defense
as potent upstream cytokines to IFNg. IL-18 conferredtion of primed Kupffer cells and macrophages in the
liver may also contribute to local secretion of a large resistance to Salmonella typhimurium and Cryptococ-
cus neoformans (Kawakami et al., 1997; Zhang et al.,amount of IL-18 upon FasL stimulation, which leads to
acute liver injury. 1997; Mastroeni et al., 1999). In such infection, IL-18
may upregulate functional FasL expression on NK cellsOur present study suggests a critical role of IL-18 in
FasL-induced liver injury, as represented by the inability and Th1 cells (Dao et al., 1996; Tsutsui et al., 1996) and
also induce production of IFNg by these cells, which inof rFasL to cause liver injury in P. acnes-primed IL-18-
deficient mice (Figure 4B). FasL has been implicated in turn upregulates functional Fas expression on macro-
phages, leading to amplification of IL-18 production.liver injury associated with various animal models of
hepatitis and liver diseases, such as viral hepatitis, alco- This positive circuit between IL-18 and Fas/FasL system
may cause rapid and massive production of IFNg, lead-holic liver cirrhosis, and Wilson's disease (Hayashi and
Miwa, 1997; Kondo et al., 1997; Seino et al., 1997; Ta- ing to effective clearance of microbes. Functional Fas
or FasL mutant mice were reported to be sensitive togawa et al., 1998; Taeb et al., 1998; Strand et al., 1998).
Since FasL is directly cytotoxic to hepatocytes in vitro, Leishmania major infection (ConceicË ao-Silva et al.,
1998). This may be explained by abrogation of FasL-it has been generally supposed that the predominant
mode of FasL action is direct cytotoxicity against liver mediated IL-18 secretion in Fas- or FasL-disrupted
mice. Thus, the FasL-stimulated IL-18 secretion fromparenchymal cells (Seino et al., 1997; Zheng et al., 1998).
However, our present results showed that soluble FasL IFNg-primed macrophages may play an important role
in amplifying the Th1-mediated inflammatory responses.did not exert direct hepatocytotoxicity in IL-18-deficient
mice even after P. acnes priming. Although soluble FasL However, an excessive acceleration of IL-18 production
by this circuit may also cause inflammatory diseasescan be efficiently secreted from activated T cells (Kaya-
gaki et al., 1995), it has been shown that cytotoxic activ- such as hepatitis and rheumatoid arthritis. We are now
investigating pathophysiological roles of the Fas/FasL-ity of soluble FasL is greatly reduced as compared to
membrane-bound FasL (Oyaizu et al., 1997; Tanaka et mediated IL-18 secretion in various inflammatory dis-
eases.al., 1998). Therefore, the predominant mode of soluble
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Experimental Procedures IL-18 and IL-12 synergistically induce IFNg production by LNK5E3
cells (data not shown). To increase sensitivity of the assay, we
measured IL-18 activity in the presence of a small amount of IL-12Mice and Reagents
Female C57BL/6 mice (6- to 8-week-old) and female C57BL/6 gld/ that alone did not induce IFNg production by LNK5E3. LNK5E3 cells
(5 3 105/ml) were incubated with 100 pg/ml of IL-12, 500 U/ml of IL-2,gld mice (6- to 8-week-old) were purchased from Japan SLC (Shizu-
oka, Japan). Caspase-1-deficient mice (Kuida et al., 1995) were and 25% macrophage supernatants, or 10% serum from variously
treated mice in the presence or absence of 100 mg/ml anti-IL-18backcrossed with C57BL/6 mice, and F5 (5- to 8-week-old, female)
were used for this study. IL-18-deficient mice (Takeda et al., 1998) antibody, which completely inhibited 100 ng/ml of recombinant mu-
rine IL-18, for 48 hr. IFNg in the culture supernatant was determinedwere also backcrossed with C57BL/6 mice, and F8 (5- to 8-week-old,
female) were used. IFNg-deficient mice (5- to 8-week-old, female) on by ELISA (Genzyme). IL-18 activity was defined as followed: IL-18
activity (U/ml) 5 (IFNg [pg/ml] in LNK5E3 supernatant without anti-C57BL/6 background were kindly provided by Dr. Y. Iwakura of
Tokyo University (Tokyo, Japan) (Tagawa et al., 1997; Hyodo et al., IL-18 antibody) - (IFNg [pg/ml] in the supernatant with anti-IL-18
antibody).1999). Heat-killed P. acnes was prepared as previously described
(Tsutsui et al., 1997). The mice that had been i.p. administered with
1 mg of P. acnes 7 days before were used as P. acnes-primed mice. ELISA for Cytokines
Neutralizing mAbs against murine FasL (MFL-1, hamster IgG, and IL-18 was measured by ELISA kits kindly provided by Hayashibara
K10, mouse IgG2b) and human FasL (NOK-1, mouse IgG1) and (Okayama, Japan), as previously reported (Matsui et al., 1997).
murine mFasL cells were generated as previously described (Kaya-
gaki et al., 1995, 1997). rFasL was prepared as previously reported Assay for Apoptosis
(Oyaizu et al., 1997). LPS derived from Escherichia coli 055:B5 was The ratio of apoptotic cells in variously treated macrophages was
purchased from Difco. ZVAD and YVAD were purchased from the determined by nuclear staining with propiodium iodide followed by
Peptide Institute (Osaka, Japan). Recombinant IL-2 was kindly pro- FACS analysis as previously reported (Nakanishi et al., 1996).
vided by Shionogi (Osaka, Japan). Normal hamster IgG and control
mouse IgG1 were purchased from PharMingen. Constitutively FasL- Induction of Liver Injury
expressing hepatic NK cell line, LNK5E3, was established from P. rFasL (500 ng) in PBS was i.v. administered into P. acnes-primed
acnes-primed BALB/c nu/nu mice, as previously reported (Tsutsui or nontreated mice with various genetic backgrounds. In some ex-
et al., 1996). Culture medium generally used in this study was RPMI- periments, P. acnes-primed C57BL/6 mice were i.p. administered
1640 supplemented with 10% FCS, 100 U/ml of penicillin, 100 mg/ with 1 mg of anti-human FasL mAb 1 hr before the administration
ml of streptomycin, 50 mM 2-ME, and 2 mM L-glutamine. of rFasL. For one experimental group, five mice were used. At 24
hr, the serum was collected for determining IL-18 and liver enzyme
levels, and the liver specimens were sampled for histological study.Preparation of Macrophages
The liver specimens were fixed and stained with HE. In some experi-Spleen cells (5 3 106/ml) isolated from nontreated or P. acnes-
ments, IL-18 (500 ng) was i.p. injected into wild-type C57BL/6 miceprimed mice were incubated in 10 cm dishes for 1 hr, and adherent
along with 1 mg of anti-mFasL mAb (K10) or control mouse IgG at daycells were harvested for splenic macrophages. Kupffer cells were
5, 6, and 7 after the administration of P. acnes. For one experimentalalso isolated from the variously treated mice, as shown previously
group, five mice were used. At 24 hr, sera were sampled for determi-(Tsutsui et al., 1997). The macrophages (1 3 106/ml) were incubated
nation of liver enzyme levels. In some experiments, IL-18 (500 ng)with 1 mg/ml of LPS, 2 3 106/ml of mFasL cells, 2 3 106/ml of LNK5E3
was i.p. injected into wild-type C57BL/6 mice (n 5 20), gld/gld micecells, or various concentrations of rFasL in the presence or absence
(n 5 20), or IFNg-deficient mice (n 5 11) at day 5, 6, and 7 after theof 10 mg/ml of anti-mouse FasL mAb or 50 mg/ml of anti-human
administration of P. acnes. At 24 hr, the sera were sampled forFasL mAb for 24 hr. The macrophages were also incubated with
determination of liver enzyme levels.various doses of rFasL in the presence or absence of 20 mM ZVAD
or YVAD for 24 hr. In some experiments, macrophages were incu-
Statisticsbated with 20 ng/ml of rFasL for 24 hr, and the cells were collected
All data are given as mean 6 SD. Significance between the controlfor analysis of apoptosis by flow cytometry. The culture superna-
group and a treated group was examined with the unpaired Stu-tants were assayed for IL-18 concentration by ELISA and IL-18
dent's t test. P values less than 0.05 were regarded as significant.activity by a bioassay, as described below.
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